If I were in my 20s, I'd buy these ASX shares

These stocks offer compelling growth potential.

| More on:
A group of young ASX investors sitting around a laptop with an older lady standing behind them explaining how investing works.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If I were in my 20s, I'd buy ASX shares that could deliver pleasing long-term capital growth.

Gains aren't guaranteed. However, I think they're more likely to come from businesses with major growth plans and/or a high return on equity (ROE), given the relationship with profit growth.

Growing profit is normally what sends share prices higher, so investors could continue to be attracted to these sorts of businesses.

I'm going to talk about two investments on the ASX that tick the box for me. One of them is an exchange-traded fund (ETF), but it's available to Aussies, so I'm calling it an ASX share.

VanEck MSCI International Quality ETF (ASX: QUAL)

This fund is built to provide investors with exposure to some of the strongest businesses in the world.

It takes a formulaic approach, rather than requiring the opinion of fund managers to decide on the quality of those companies.

There are three key factors that count towards a quality score for businesses. First, a high ROE, second, earnings stability and third, low financial leverage.

This means the businesses make a lot of profit on shareholder money retained within the business, profit doesn't (usually) fall, and the businesses have little debt considering the scale of the company.

This combination of factors is very appealing because a company that has all three attributes is likely to deliver good profit growth.

Past performance is not a guarantee of future performance of course, but in the five years to 31 March 2025 the QUAL ETF returned an average of 16% per year. I think this demonstrates the quality of the underlying businesses and they could continue doing well in the coming years.

Tuas Ltd (ASX: TUA)

Tuas is a telecommunications business based in Singapore. The ASX share has won over 1 million mobile services with a focus on providing great value. At the end of 31 January 2025, being the FY25 first half, it reached 1.16 million subscribers (up 23.7% year-over-year).

Excitingly, the ASX share has also recently started with a home broadband offering. It had 14,347 broadband subscribers at the end of the HY25 result and I'm optimistic it can add tens of thousands of customers in this division in the coming reporting periods.

The business has grown rapidly and I'm excited about what it can achieve in the coming years, particularly if it expands to other Asian countries such as Malaysia and Indonesia. HY25 revenue grew 33.8% to $73.2 million and operating profit (EBITDA) jumped by 47.8% to $33.1 million. It's a great sign that profit is growing faster than revenue because it could mean margins could continue rising in the coming years.

I'd happily buy more of this ASX share at the current Tuas share price because of its earnings growth potential over the next five years.

Motley Fool contributor Tristan Harrison has positions in Tuas and VanEck Msci International Quality ETF. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

A doctor or medical expert in COVID protection adjusts her glasses, indicating growth or strong share price movement in ASX medical, biotech and health companies
Opinions

Forget CSL shares, I'd buy this booming biotech stock instead

This ASX biotech stock has caught my eye this year.

Read more »

A medical researcher rests his forehead on his fist with a dejected look on his face while sitting behind a scientific microscope with another researcher's hand on his shoulder as if giving comfort.
Healthcare Shares

Telix Pharmaceuticals shares crash 58% from their peak: Buying opportunity or time to sell up?

The biopharmaceutical company's shares are tipped to soar next year.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

Smiling woman with her head and arm on a desk holding $100 notes out, symbolising dividends.
Dividend Investing

1 ASX dividend stock down 17% I'd buy right now

I’d happily do some pre-Christmas portfolio shopping with this ASX dividend stock.

Read more »

Green arrow with green stock prices symbolising a rising share price.
Opinions

2 ASX shares to buy and hold for the next decade

I’m backing these ASX shares as long-term buys.

Read more »

a hand reaches out with australian banknotes of various denominations fanned out.
Opinions

2 incredible ASX shares I'd buy with $2,000 right now

These investments have global growth potential…

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Opinions

I'd buy this ASX dividend stock in any market

I’m planning to buy plenty more of this ASX stock in the coming months…

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

3 Aussie passive income stocks delivering decades upon decades of dividends

Income-focused investors could benefit from these stocks.

Read more »